Short Interest in CapsoVision, Inc. (NASDAQ:CV) Rises By 430.0%

Key Points

• Short interest in CapsoVision, Inc. increased by 430.0% in September, reaching a total of 10,600 shares sold short.
• Research analysts have given CapsoVision a consensus rating of "Strong Buy" with a price target averaging $5.50.
• The company reported a (2.02) earnings per share, missing estimates, despite revenues of $3.32 million for the quarter.

CapsoVision, Inc. (NASDAQ:CV - Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 10,600 shares, an increase of 430.0% from the August 31st total of 2,000 shares. Approximately 0.0% of the company's stock are sold short. Based on an average daily volume of 251,100 shares, the short-interest ratio is currently 0.0 days. Based on an average daily volume of 251,100 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company's stock are sold short.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Roth Capital set a $6.00 target price on CapsoVision and gave the stock a "buy" rating in a research report on Monday, July 28th. Wall Street Zen upgraded CapsoVision to a "hold" rating in a report on Sunday, July 13th. Finally, Benchmark started coverage on shares of CapsoVision in a research note on Monday, July 28th. They issued a "speculative buy" rating and a $5.00 target price for the company. One analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Strong Buy" and a consensus price target of $5.50.

CapsoVision Trading Up 6.8%

NASDAQ:CV opened at $4.84 on Wednesday. CapsoVision has a 1 year low of $3.43 and a 1 year high of $5.72. The firm has a fifty day moving average price of $4.11.

CapsoVision (NASDAQ:CV - Get Free Report) last posted its quarterly earnings data on Thursday, August 14th. The company reported ($2.02) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($1.91). The company had revenue of $3.32 million during the quarter, compared to analyst estimates of $3.20 million.

CapsoVision Company Profile

We are a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in our capsule endoscopy solutions to identify abnormalities of the gastrointestinal (“GI”) tract for diagnostic and screening purposes. We developed our first capsule endoscope system, currently comprising the CapsoCam Plus single-usecapsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn's disease.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.